Amir Weiss - 21 Aug 2026 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Reporting relationship: Chief Accounting Officer
Issuer ticker: TEVA
Reported as of: 21 Aug 2026
Net transaction value: -$355,301
SEC form: 4
Accepted by SEC: 25 Aug 2026, 16:05:09 UTC
Prior SEC filing: 07 May 2026
Source filing: View source filing
Reporting owner signature: Dov Bergwerk as attorney-in-fact for Amir Weiss

Key filing fact

Amir Weiss filed Form 4 for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on 25 Aug 2026.

Key facts

This page summarizes Amir Weiss's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 25 Aug 2026, 16:05.

Change

Previous filing in this sequence was filed on 07 May 2026.
Current net transaction value: -$355,301.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001897057 Primary reporting owner

Weiss Amir

Relationship: Chief Accounting Officer
Address: C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, ISRAEL
Signature: Dov Bergwerk as attorney-in-fact for Amir Weiss
Signature date: 25 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TEVA transaction

Ordinary Shares

Sale

Transaction value: $261,224
Shares: -6,945
Change %: -35%
Price: $37.61
Shares after: 13,071
Date: 21 Aug 2026
Ownership: Direct
Footnotes: F1, F2

TEVA transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +2,500
Change %: +19%
Price: $19.61^*
Shares after: 15,571
Date: 21 Aug 2026
Ownership: Direct
Footnotes: F1

TEVA transaction

Ordinary Shares

Sale

Transaction value: $94,077
Shares: -2,500
Change %: -16%
Price: $37.63
Shares after: 13,071
Date: 21 Aug 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TEVA transaction Derivative

Stock Options (right to buy)

Options Exercise

Transaction value
Shares: -2,500
Change %: -25%
Price: $19.16^*
Shares after: 7,502
Date: 21 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 2,500
Exercise price: $19.16
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.61 to $31.62, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F3

Stock options were granted on March 3, 2018, with 2,500 having vested on each of March 2, 2019, March 2, 2020 and March 2, 2021 and 2,502 having vested on March 2, 2022.